Abnormal expression of genes related to apoptosis was also reported in bone marrow CD34+ cells isolated from three DBA patients with mutations in RPS19 and in remission from the disease (Gazda et al., 2006), and in a previous study by our group focused on unraveling the gene expression alterations in fibroblasts isolated from DBA patients with RPS19 mutations (Avondo et al., 2009). The gene discussed is RPS19; the disease is Diamond-Blackfan anemia.